Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Antialbuminuric Effects of Valsartan and Lisinopril

This study has been terminated.
(unknown)
Sponsor:
Information provided by (Responsible Party):
Novartis
ClinicalTrials.gov Identifier:
NCT00171600
First received: September 12, 2005
Last updated: November 7, 2011
Last verified: November 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: January 2007
  Primary Completion Date: January 2007 (Final data collection date for primary outcome measure)